Leukemia Society of America Workshop Abstracts Antisense Molecular Therapy

ISSN： 1079-9796

Source： Blood Cells, Molecules, and Diseases, Vol.26, Iss.1, 2000-02, pp. : 54-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute promyelocytic leukemia: A model of molecular target based therapy

By Zhou Guang-Biao Chen Sai-Juan Chen Zhu

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 270-280

Maney Publishing

Access to resources Recommend Favorite

Antisense therapy to ameliorate DMD

By Ramsay M.

Trends in Molecular Medicine, Vol. 7, Iss. 3, 2001-03 ,pp. : 101-101

Elsevier

Access to resources Recommend Favorite

Complete molecular remission of chronic eosinophilic leukemia complicated by CNS disease after targeted therapy with imatinib

By Frickhofen Norbert

Annals of Hematology, Vol. 83, Iss. 7, 2004-07 ,pp. : 477-480

Springer Publishing Company

Access to resources Recommend Favorite

Advances in Stem Cell Therapy for Leukemia

Current Stem Cell Research & Therapy, Vol. 11, Iss. 2, 2016-02 ,pp. : 158-165

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Stem Cell Therapy for Leukemia

Current Stem Cell Research & Therapy, Vol. 11, Iss. 2, 2016-01 ,pp. : 158-165

Bentham Science Publishers

Access to resources Recommend Favorite